ASTH
Price
$24.50
Change
-$0.29 (-1.17%)
Updated
Jun 2 closing price
Capitalization
1.88B
58 days until earnings call
EXETF
Price
$10.51
Change
-$0.01 (-0.10%)
Updated
May 28 closing price
Capitalization
459.44M
71 days until earnings call
Interact to see
Advertisement

ASTH vs EXETF

Header iconASTH vs EXETF Comparison
Open Charts ASTH vs EXETFBanner chart's image
Astrana Health
Price$24.50
Change-$0.29 (-1.17%)
Volume$195K
Capitalization1.88B
Extendicare
Price$10.51
Change-$0.01 (-0.10%)
Volume$3.05K
Capitalization459.44M
ASTH vs EXETF Comparison Chart
Loading...
ASTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASTH vs. EXETF commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Buy and EXETF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (ASTH: $24.50 vs. EXETF: $10.51)
Brand notoriety: ASTH and EXETF are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ASTH: 72% vs. EXETF: 63%
Market capitalization -- ASTH: $1.88B vs. EXETF: $459.44M
ASTH [@Medical/Nursing Services] is valued at $1.88B. EXETF’s [@Medical/Nursing Services] market capitalization is $459.44M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $4.28B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 0 FA rating(s) are green whileEXETF’s FA Score has 2 green FA rating(s).

  • ASTH’s FA Score: 0 green, 5 red.
  • EXETF’s FA Score: 2 green, 3 red.
According to our system of comparison, EXETF is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 4 TA indicator(s) are bullish.

  • ASTH’s TA Score: 4 bullish, 6 bearish.

Price Growth

ASTH (@Medical/Nursing Services) experienced а +0.86% price change this week, while EXETF (@Medical/Nursing Services) price change was +2.05% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.06%. For the same industry, the average monthly price growth was +2.82%, and the average quarterly price growth was +13.31%.

Reported Earning Dates

ASTH is expected to report earnings on Jul 31, 2025.

EXETF is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Medical/Nursing Services (+3.06% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASTH($1.88B) has a higher market cap than EXETF($459M). EXETF has higher P/E ratio than ASTH: EXETF (140.85) vs ASTH (32.55). EXETF YTD gains are higher at: 44.580 vs. ASTH (-22.296). ASTH has higher annual earnings (EBITDA): 124M vs. EXETF (57.3M). ASTH has more cash in the bank: 296M vs. EXETF (105M). ASTH has less debt than EXETF: ASTH (321M) vs EXETF (397M). ASTH has higher revenues than EXETF: ASTH (1.39B) vs EXETF (1.24B).
ASTHEXETFASTH / EXETF
Capitalization1.88B459M410%
EBITDA124M57.3M216%
Gain YTD-22.29644.580-50%
P/E Ratio32.55140.8523%
Revenue1.39B1.24B112%
Total Cash296M105M282%
Total Debt321M397M81%
FUNDAMENTALS RATINGS
ASTH vs EXETF: Fundamental Ratings
ASTH
EXETF
OUTLOOK RATING
1..100
5675
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
13
Undervalued
PROFIT vs RISK RATING
1..100
8817
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8738
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EXETF's Valuation (13) in the null industry is somewhat better than the same rating for ASTH (52). This means that EXETF’s stock grew somewhat faster than ASTH’s over the last 12 months.

EXETF's Profit vs Risk Rating (17) in the null industry is significantly better than the same rating for ASTH (88). This means that EXETF’s stock grew significantly faster than ASTH’s over the last 12 months.

EXETF's SMR Rating (100) in the null industry is in the same range as ASTH (100). This means that EXETF’s stock grew similarly to ASTH’s over the last 12 months.

EXETF's Price Growth Rating (38) in the null industry is somewhat better than the same rating for ASTH (87). This means that EXETF’s stock grew somewhat faster than ASTH’s over the last 12 months.

EXETF's P/E Growth Rating (100) in the null industry is in the same range as ASTH (100). This means that EXETF’s stock grew similarly to ASTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTH
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CELU2.240.13
+6.16%
Celularity
AURA6.160.30
+5.12%
Aura Biosciences
BB4.040.08
+2.02%
BlackBerry Limited
SNPS466.152.17
+0.47%
Synopsys
BYD74.35-0.62
-0.83%
Boyd Gaming Corp

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
-1.17%
ACHC - ASTH
46%
Loosely correlated
-4.46%
DCGO - ASTH
41%
Loosely correlated
+4.93%
AMN - ASTH
39%
Loosely correlated
-3.84%
AGL - ASTH
39%
Loosely correlated
+1.35%
PNTG - ASTH
36%
Loosely correlated
+0.42%
More

EXETF and

Correlation & Price change

A.I.dvisor tells us that EXETF and FSNUF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXETF and FSNUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXETF
1D Price
Change %
EXETF100%
N/A
FSNUF - EXETF
28%
Poorly correlated
N/A
AIRS - EXETF
27%
Poorly correlated
+1.13%
INNV - EXETF
23%
Poorly correlated
-4.40%
ASTH - EXETF
22%
Poorly correlated
-1.17%
THC - EXETF
22%
Poorly correlated
+0.80%
More